Elucida Oncology to Present Trials in Progress Poster for Phase 1/2 Study of ELU001 in Patients with…
MONMOUTH JUNCTION, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company…
Read More...
Read More...
Browsing Tag
Elucida
Elucida Oncology to Present at the Bank of America 2022 Healthcare Conference
MONMOUTH JUNCTION, N. J. , May 06, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company…
Read More...
Read More...
Elucida Oncology Announces First Patient Dosed in Phase 1/2 Study of ELU001 in Patients with…
MONMOUTH JUNCTION, N.J., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the…
Read More...
Read More...